150 related articles for article (PubMed ID: 32951929)
1. Measuring the Quality of Diagnostic Prostate Magnetic Resonance Imaging: A Urologist's Perspective.
Giannarini G; Valotto C; Girometti R; Dal Moro F; Briganti A; Padhani AR
Eur Urol; 2021 Apr; 79(4):440-441. PubMed ID: 32951929
[TBL] [Abstract][Full Text] [Related]
2. Prostate MRI and image quality: The urologist's perspective.
Khan A; Moore CM; Minhaj Siddiqui M
Eur J Radiol; 2024 Jan; 170():111255. PubMed ID: 38101197
[TBL] [Abstract][Full Text] [Related]
3. Prostate MRI: a national survey of Urologist's attitudes and perceptions.
Manley BJ; Brockman JA; Raup VT; Fowler KJ; Andriole GL
Int Braz J Urol; 2016; 42(3):464-71. PubMed ID: 27286108
[TBL] [Abstract][Full Text] [Related]
4. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.
Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841
[TBL] [Abstract][Full Text] [Related]
5. A urologist's perspective on prostate cancer imaging: past, present, and future.
George AK; Turkbey B; Valayil SG; Muthigi A; Mertan F; Kongnyuy M; Pinto PA
Abdom Radiol (NY); 2016 May; 41(5):805-16. PubMed ID: 27138438
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging for prostate cancer: what the urologist needs to know.
Kiechle J; Pahwa S; Gulani V; Kanaan G; Sedelaar J; Ponsky L
Minerva Urol Nefrol; 2015 Sep; 67(3):201-10. PubMed ID: 26054410
[TBL] [Abstract][Full Text] [Related]
7. [Prostate gland - what would urologists like to know from radiologists?].
Liehr UB; Baumunk D; Blaschke S; Fischbach F; Friebe B; König F; Lemke A; Mittelstädt P; Pech M; Porsch M; Ricke J; Schindele D; Siedentopf S; Wendler JJ; Schostak M
Radiologe; 2017 Aug; 57(8):608-614. PubMed ID: 28660295
[TBL] [Abstract][Full Text] [Related]
8. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.
Drost FH; Osses D; Nieboer D; Bangma CH; Steyerberg EW; Roobol MJ; Schoots IG
Eur Urol; 2020 Jan; 77(1):78-94. PubMed ID: 31326219
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
10. End-user evaluation of software-generated intervention planning environment for transrectal magnetic resonance-guided prostate biopsies.
Velazco-Garcia JD; Navkar NV; Balakrishnan S; Abi-Nahed J; Al-Rumaihi K; Darweesh A; Al-Ansari A; Christoforou EG; Karkoub M; Leiss EL; Tsiamyrtzis P; Tsekos NV
Int J Med Robot; 2021 Feb; 17(1):1-12. PubMed ID: 33047863
[TBL] [Abstract][Full Text] [Related]
11. ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
de Rooij M; Israël B; Tummers M; Ahmed HU; Barrett T; Giganti F; Hamm B; Løgager V; Padhani A; Panebianco V; Puech P; Richenberg J; Rouvière O; Salomon G; Schoots I; Veltman J; Villeirs G; Walz J; Barentsz JO
Eur Radiol; 2020 Oct; 30(10):5404-5416. PubMed ID: 32424596
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Magnetic Resonance Imaging-directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis.
Schoots IG; Padhani AR; Rouvière O; Barentsz JO; Richenberg J
Eur Urol Oncol; 2020 Feb; 3(1):32-41. PubMed ID: 31706946
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of the prostate: interpretation using the PI-RADS V2.
Torregrosa Andrés A; Otero García M; Sineiro Galiñanes M
Radiologia; 2017; 59(2):128-138. PubMed ID: 28012730
[TBL] [Abstract][Full Text] [Related]
14. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.
Muthigi A; Sidana A; George AK; Kongnyuy M; Maruf M; Valayil S; Wood BJ; Pinto PA
Urol Oncol; 2017 Jan; 35(1):32.e1-32.e7. PubMed ID: 27743850
[TBL] [Abstract][Full Text] [Related]
15. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project.
Scheltema MJ; Tay KJ; Postema AW; de Bruin DM; Feller J; Futterer JJ; George AK; Gupta RT; Kahmann F; Kastner C; Laguna MP; Natarajan S; Rais-Bahrami S; Rastinehad AR; de Reijke TM; Salomon G; Stone N; van Velthoven R; Villani R; Villers A; Walz J; Polascik TJ; de la Rosette JJMCH
World J Urol; 2017 May; 35(5):695-701. PubMed ID: 27637908
[TBL] [Abstract][Full Text] [Related]
16. Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool.
Gaziev G; Wadhwa K; Barrett T; Koo BC; Gallagher FA; Serrao E; Frey J; Seidenader J; Carmona L; Warren A; Gnanapragasam V; Doble A; Kastner C
BJU Int; 2016 Jan; 117(1):80-6. PubMed ID: 25099182
[TBL] [Abstract][Full Text] [Related]
17. Structured reporting of prostate magnetic resonance imaging has the potential to improve interdisciplinary communication.
Wetterauer C; Winkel DJ; Federer-Gsponer JR; Halla A; Subotic S; Deckart A; Seifert HH; Boll DT; Ebbing J
PLoS One; 2019; 14(2):e0212444. PubMed ID: 30779810
[TBL] [Abstract][Full Text] [Related]
18. Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD).
Falagario UG; Jambor I; Lantz A; Ettala O; Stabile A; Taimen P; Aronen HJ; Knaapila J; Perez IM; Gandaglia G; Fossati N; Martini A; Cucchiara V; Picker W; Haug E; Ratnani P; Haines K; Lewis S; Sujit N; Selvaggio O; Sanguedolce F; Macarini L; Cormio L; Nordström T; Tewari A; Briganti A; Boström PJ; Carrieri G
Eur Urol Oncol; 2021 Dec; 4(6):971-979. PubMed ID: 32972896
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
Mowatt G; Scotland G; Boachie C; Cruickshank M; Ford JA; Fraser C; Kurban L; Lam TB; Padhani AR; Royle J; Scheenen TW; Tassie E
Health Technol Assess; 2013 May; 17(20):vii-xix, 1-281. PubMed ID: 23697373
[TBL] [Abstract][Full Text] [Related]
20. Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
Giganti F; Dinneen E; Kasivisvanathan V; Haider A; Freeman A; Kirkham A; Punwani S; Emberton M; Shaw G; Moore CM; Allen C
Eur Radiol; 2022 Feb; 32(2):879-889. PubMed ID: 34327583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
